http://finance.yahoo.com/news/investor-notice-lundin-law-pc-
INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc.
According to the complaint, the Company issued materially false and misleading statements to investors regarding the efficacy and safety of Eravacycline, and its capacity for approval by both the U.S. Food and Drug Administration (“FDA”) and the European Medicines Agency (“EMA”).